catalyst

A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2014-11-17 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia — primary completion
Type
Trial Readout
Date
2014-11-17
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
trial